University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0NR, United Kingdom.
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
Eur J Pharm Biopharm. 2022 Feb;171:11-18. doi: 10.1016/j.ejpb.2021.12.014. Epub 2022 Jan 4.
In this study, the use of a microwave reactor, which allowed high input of energy into a pressurised system in a short period of time, was investigated for preparation of lipid nanoparticles (LNPs). The aim was to optimise the formulation process by reducing manufacturing time. Two types of LNPs were prepared; non-ionic surfactant vesicles (NISV) and bilosomes (modified NISV incorporating bile salts), with a model antigen (tetanus toxoid, TT) and the immune response induced after mucosal (nasal and oral, respectively) administration was assessed. The TT loaded LNPs were characterised in terms of particle size, size distribution, morphology, and entrapment efficiency. Immunisation was evaluated by lethal challenge with tetanus toxin in an animal model. The efficiency of vaccination was evaluated by measuring the anti-TT IgG antibody levels in the vaccinated animals. Bilosomes formed by this method showed an immunogen entrapment efficiency of ∼30% which was significantly (p < 0.05) higher than entrapment efficiency in the NISV. The percentage of animals that survived when challenged with tetanus toxin correlated with the level of IgG determined in the serum of mice immunised with LNPs by the mucosal route. Moreover, there were significant (p < 0.05) differences between orally and nasally immunised groups. Animal groups immunised bilosomes via the oral route showed the highest level of IgG (1.2 ± 0.13) compared to the positive control, LN + Xn, and no immunised group. Similarly, groups immunised via the nasal route showed significantly (p < 0.0001) higher titres compared with the control group. Mucosal TT was capable of inducing systemic specific IgG anti-TT responses that were higher than the parenteral vaccine.
在这项研究中,使用微波反应器在短时间内将大量能量输入加压系统,以研究其在制备脂质纳米粒(LNPs)中的应用。目的是通过缩短制造时间来优化制剂工艺。制备了两种 LNPs:非离子表面活性剂囊泡(NISV)和双分子层囊泡(改良的 NISV,掺入胆盐),并以模型抗原(破伤风类毒素,TT)为模型,评估了经粘膜(鼻内和口服)给药后的免疫反应。用 TT 负载的 LNPs 的粒径、粒径分布、形态和包封效率进行了表征。用破伤风毒素对动物模型进行致死性攻击来评估免疫接种的效率。通过测量接种动物中的抗 TT IgG 抗体水平来评估疫苗接种的效率。通过这种方法形成的双分子层囊泡的免疫原包封效率约为 30%,显著(p<0.05)高于 NISV 的包封效率。用破伤风毒素攻击时,存活的动物百分比与经粘膜途径用 LNPs 免疫的小鼠血清中 IgG 水平相关。此外,口服和鼻内免疫组之间存在显著差异(p<0.05)。经口服途径用双分子层囊泡免疫的动物组显示出最高水平的 IgG(1.2±0.13),与阳性对照 LN+Xn 和未免疫组相比。同样,经鼻内途径免疫的组与对照组相比,显示出显著更高的滴度(p<0.0001)。粘膜 TT 能够诱导高于全身疫苗的系统特异性 IgG 抗 TT 反应。